MedPath

Clinical trial to study the efficacy of Panchvalkala Kwatha in Shayyamutrata (Enuresis) in children of age 6 to 12 years.

Phase 2
Conditions
Health Condition 1: F99- Mental disorder, not otherwise specified
Registration Number
CTRI/2023/10/059066
Lead Sponsor
Dr Rutuja Rahul Kate
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Children complaining of Shayyamutrata i.e. enuresis between 6 to 12 years age group will be selected

•Repeated voiding of urine in the bed or clothes,2 or more than 2 times in a week, for at least 3 months.

Exclusion Criteria

•Patients having systemic disorders like Diabetes Mellitus and Diabetes Insipidus.

•Patients with congenital anomalies or with anatomical defect in genital urinary system and UTI.

•Neurodevelopment disorders like Mental Retardation, Cerebral Palsy, Spina bifida and seizure disorders.

•Any systemic severe illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o bedwetting or decreased frequency of bedwetting at the end of 60 daysTimepoint: 0 Day <br/ ><br>16th day <br/ ><br>31st day <br/ ><br>60th day
Secondary Outcome Measures
NameTimeMethod
To study the adverse effects of the Panchvalkala Kwatha.Timepoint: 60 days
© Copyright 2025. All Rights Reserved by MedPath